Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: E'Lane who wrote (7028)	4/14/1998 8:37:00 PM
From: Chip Roos	Read Replies (2) \| Respond to of 23519

Bye all and good luck - I really mean it. Chip

To: E'Lane who wrote (7028)	4/14/1998 10:26:00 PM
From: Bradpalm1	Read Replies (3) \| Respond to of 23519

E'Lane, The 1998 PDR was published months prior to Viagra's approval. Full prescribing information will come out in a scheduled PDR addendum release in the next several weeks. The 1999 PDR will be published containing Viagra's complete prescribing information in all its glory. In the meantime, Pfizer reps have been dropping off detailed prescribing information over the last 2 days and will start bringing professional Viagra samples to our office on Thursday. According to them, $200,000,000 worth of Viagra has been sold through pharmacies throughout the country thus far. The European rollout of the drug should also happen shortly since MCA approval was concurrent with FDA approval of Viagra. Bradpalm1